Market Capitalization (Millions $) |
1,920 |
Shares
Outstanding (Millions) |
121 |
Employees |
1,259 |
Revenues (TTM) (Millions $) |
592 |
Net Income (TTM) (Millions $) |
-251 |
Cash Flow (TTM) (Millions $) |
14 |
Capital Exp. (TTM) (Millions $) |
51 |
10x Genomics Inc
10x Genomics Inc. is a life science technology company that specializes in developing and manufacturing next-generation sequencing platforms and associated software tools. The company was founded in 2012 and is headquartered in Pleasanton, California. The company's core technology is based on a droplet-based synthetic biology approach that enables the parallel analysis of thousands of individual cells or DNA molecules at the same time, greatly speeding up the pace of genomic research. 10x Genomics offers several products and services that leverage this technology, including single-cell and spatial gene expression solutions, immune profiling, and genome assembly. 10x Genomics' flagship product is the Chromium System, a high-throughput single-cell analysis platform that can process up to 10,000 cells in a single run. The Chromium System enables researchers to generate high-quality gene expression data at a single-cell resolution, allowing for the identification and characterization of rare cell populations and the discovery of new biomarkers. In addition to its research-focused offerings, 10x Genomics has also developed several clinical-grade products, including the Visium Spatial Gene Expression Solution, which enables spatial mapping of gene expression on tissue sections. The company's products have been used in a wide range of applications, including cancer immunotherapy research, drug discovery, and agricultural genomics. In terms of financials, 10x Genomics has experienced rapid growth since its founding, with reported revenues of $100 million in 2017, $245 million in 2018, and $375 million in 2019. The company's stock is publicly traded on the NASDAQ stock exchange under the ticker symbol TXG. Overall, 10x Genomics is a cutting-edge life science technology company that has developed innovative solutions for genomic research and analysis. Its technology and products have the potential to transform the way we understand and treat complex diseases, making it a key player in the rapidly-evolving genomics market.
Company Address: 6230 Stoneridge Mall Road Pleasanton 94588 CA
Company Phone Number: 401-7300 Stock Exchange / Ticker: NASDAQ TXG
|